Current treatment Melioidosis

^ cite error: named reference prevention. melioidosis 2012 invoked never defined (see page).
^ white nj, dance da, chaowagul w, et al. (1989). halving of mortality of severe melioidosis ceftazidime . lancet. 2 (8665): 697–701. doi:10.1016/s0140-6736(89)90768-x. pmid 2570956. 
^ chierakul w, anunnatsiri s, chaowagul w, et al. (2007). addition of trimethoprim-sulfamethoxazole ceftazidime during parenteral treatment of melioidosis not associated long-term outcome benefit . clinical infectious diseases. 45 (4): 521–523. doi:10.1086/520010. pmid 17638209. 
^ cheng ac, fisher da, anstey nm, et al. (2004). outcomes of patients melioidosis treated meropenem . antimicrob agents chemother. 48 (5): 1763–65. doi:10.1128/aac.48.5.1763-1765.2004. pmc 400582 . pmid 15105132. 
^ cite error: named reference simpson1999 invoked never defined (see page).
^ chetchotisakd p, porramatikul s, mootsikapun p, anunnatsiri s, thinkhamrop b (2001). randomized, double-blind, controlled study of cefoperazone-sulbactam plus cotrimoxazole versus ceftazidime plus cotrimoxazole treatment of severe melioidosis . clinical infectious diseases. 33 (1): 29–33. doi:10.1086/320878. pmid 11389491. 
^ dance da, wuthiekanun v, white nj, chaowagul w (1988). antibiotic resistance in pseudomonas pseudomallei . lancet. 1 (8592): 994–995. doi:10.1016/s0140-6736(88)91810-7. pmid 2896855. 
^ suputtamongkol y, rajchanuwong a, chaowagul w, et al. (1994). ceftazidime vs. amoxicillin/clavulanate in treatment of severe melioidosis . clinical infectious diseases. 19 (5): 846–853. doi:10.1093/clinids/19.5.846. pmid 7893868. 
^ cite error: named reference currie2000 invoked never defined (see page).
^ university of oxford (18 december 2007). randomized double blinded comparison of ceftazidime , meropenem in severe melioidosis (atom) . clinicaltrials.gov. national institutes of health. retrieved 27 jan 2011. 
^ simpson, a. j. h.; opal, s. m.; angus, b. j.; prins, j. m.; palardy, j. e.; parejo, n. a.; chaowagul, w.; white, n. j. (2000). differential antibiotic-induced endotoxin release in severe melioidosis . journal of infectious diseases. 181 (3): 1014–1019. doi:10.1086/315306. pmid 10720525. 
^ bilgrami, i.; roberts, j. a.; wallis, s. c.; thomas, j.; davis, j.; fowler, s.; goldrick, p. b.; lipman, j. (2010). meropenem dosing in critically ill patients sepsis receiving high-volume continuous venovenous hemofiltration . antimicrobial agents , chemotherapy. 54 (7): 2974–2978. doi:10.1128/aac.01582-09. pmc 2897321 . pmid 20479205. 
^ shih h-i; chuang y-c; cheung bm-h; et al. (february 2008). sporadic , outbreak cases of melioidosis in southern taiwan: clinical features , antimicrobial susceptibility . infection. 37 (1): 9–15. doi:10.1007/s15010-008-7324-8. pmid 18854938. 
^ harris p, engler c, norton r (2011). comparative in vitro susceptibility of burkholderia pseudomallei doripenem, ertapenem, tigecycline , moxifloxacin . international journal of antimicrobia agents. 37 (6): 547–549. doi:10.1016/j.ijantimicag.2011.02.001. 
^ thamlikitkul v, trakulsomboon s (2010). in vitro activity of biapenem against burkholderia pseudomallei . international journal of antimicrobia agents. 35 (5): 514. doi:10.1016/j.ijantimicag.2010.01.002. pmid 20188524. 
^ cheng ac, limmathurotsakul d, chierakul w, et al. (2007). randomized controlled trial of granulocyte colony-stimulating factor treatment of severe sepsis due melioidosis in thailand . clinical infectious diseases. 45 (3): 308–314. doi:10.1086/519261. pmid 17599307. 
^ chierakul w, anunnatsiri s, short jm, et al. (2005). 2 randomized controlled trials of ceftazidime alone versus ceftazidime in combination trimethoprim-sulfamethoxazole treatment of severe melioidosis . clinicl infectious diseases. 41 (8): 1105–1113. doi:10.1086/444456. pmid 16163628. 
^ chierakul w, anunnatsiri s, chaowagul w, peacock sj, chetchotisakd p, day np (2007). addition of trimethoprim-sulfamethoxazole ceftazidime during parenteral treatment of melioidosis not associated tong-term outcome benefit . clinical infectious diseases. 45 (4): 521–523. doi:10.1086/520010. pmid 17638209. 
^ chaowagul w, simpson aj, suputtamongkol y, et al. (1999). comparison of chloramphenicol, trimethoprim-sulfamethoxazole, , doxycycline doxycycline alone maintenance therapy melioidosis . clinical infectious diseases. 29 (2): 375–380. doi:10.1086/520218. pmid 10476745. 
^ rajchanuvong a, chaowagul w, suputtamongkol y, smith md, dance da, white nj (1995). prospective comparison of co-amoxiclav , combination of chloramphenicol, doxycycline, , co-trimoxazole oral maintenance treatment of melioidosis . transactions of royal society of tropical medicine , hygiene. 89 (5): 546–549. doi:10.1016/0035-9203(95)90104-3. pmid 8560537. 
^ cheng ac, chierakul w, chaowagul w, et al. (2008). short report: consensus guidelines dosing of amoxicillin-clavulanate in melioidosis . american journal of tropical medicine , hygiene. 78 (2): 208–209. pmc 3034162 . pmid 18256414. 
^ chaowagul w, supputtamongkul y, smith md, white nj (1997). oral fluoroquinolones maintenance treatment of melioidosis . transactions of royal society of tropical medicine , hygiene. 91 (5): 599–601. doi:10.1016/s0035-9203(97)90044-4. pmid 9463680. 
^ chetchotisakd p, chaowagul w, mootsikapun p, budhsarawong d, thinkamrop b (jan–feb 2001). maintenance therapy of melioidosis ciprofloxacin plus azithromycin compared cotrimoxazole plus doxycycline . american journal of tropical medicine , hygiene. 64 (1–2): 24–27. pmid 11425157. 
^ chaowagul w,; simpson, andrew j. h.; suputtamongkol, yupin; smith, michael d.; angus, brian j.; white, nicholas j. (august 1999). clin infect dis . clinical infectious diseases. 29 (2): 375–380. doi:10.1086/520218. pmid 10476745. 
^ limmathurotsakul d; chaowagul w; chierakul wirongrong; et al. (2006). risk factors recurrent melioidosis in northeastern thailand . clinical infectious diseases. 43 (8): 979–986. doi:10.1086/507632. pmid 16983608. 
^ dance da, wuthiekanun v, chaowagul w, white nj (1989). interactions in vitro between agents used treat melioidosis . journal of antimicrobial chemotherapy. 24 (3): 311–316. doi:10.1093/jac/24.3.311. pmid 2681117. 
^ chetchotisakd, p; chierakul, w; chaowagul, w; anunnatsiri, s; phimda, k; mootsikapun, p; chaisuksant, s; pilaikul, j; thinkhamrop, b; phiphitaporn, s; susaengrat, w; toondee, c; wongrattanacheewin, s; wuthiekanun, v; chantratita, n; thaipadungpanit, j; day, np; limmathurotsakul, d; peacock, sj (1 march 2014). trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline oral eradicative treatment melioidosis (merth): multicentre, double-blind, non-inferiority, randomised controlled trial . lancet. 383 (9919): 807–814. doi:10.1016/s0140-6736(13)61951-0. pmc 3939931 . pmid 24284287. 
^ cheng ac, mcbryde es, wuthiekanun v, chierakul w, amornchai p, day np, peacock sj (2009). dosing regimens of cotrimoxazole (trimethoprim-sulfamethoxazole) melioidosis . antimicrobial agents , chemotherapy. 53 (10): 4193–4199. doi:10.1128/aac.01301-08. pmc 2764189 . pmid 19620336.